Xenotropic Murine Leukemia Virus–Related Virus Prevalence in Patients with Chronic Fatigue Syndrome or Chronic Immunomodulatory Conditions | Zendy

Timothy J. Henrich | Zendy; Jonathan Z. Li | Zendy; Donna Felsenstein | Zendy; Camille N. Kotton | Zendy; Robert M. Plenge | Zendy; Florencia Pereyra | Zendy; Francisco M. Marty | Zendy; Nina Lin | Zendy; Paul Grazioso | Zendy; Danielle M. Crochiere | Zendy; Daniel Eggers | Zendy; Daniel R. Kuritzkes | Zendy; Athe Tsibris | Zendy

Open Access

Xenotropic Murine Leukemia Virus–Related Virus Prevalence in Patients with Chronic Fatigue Syndrome or Chronic Immunomodulatory Conditions

Author(s) -

Timothy J. Henrich,

Jonathan Z. Li,

Donna Felsenstein,

Camille N. Kotton,

Robert M. Plenge,

Florencia Pereyra,

Francisco M. Marty,

Nina Lin,

Paul Grazioso,

Danielle M. Crochiere,

Daniel Eggers,

Daniel R. Kuritzkes,

Athe Tsibris

Publication year - 2010

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/657168

Subject(s) - chronic fatigue syndrome , medicine , virus , immunology , rheumatoid arthritis , leukemia , chronic fatigue , cohort , arthritis , virology

We investigated the prevalence of xenotropic murine leukemia virus-related virus (XMRV) among 293 participants seen at academic hospitals in Boston, Massachusetts. Participants were recruited from the following 5 groups of patients: chronic fatigue syndrome (n = 32), human immunodeficiency virus infection (n = 43), rheumatoid arthritis (n = 97), hematopoietic stem-cell or solid organ transplant (n = 26), or a general cohort of patients presenting for medical care (n = 95). XMRV DNA was not detected in any participant samples. We found no association between XMRV and patients with chronic fatigue syndrome or chronic immunomodulatory conditions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research